FTSE plummets as markets rocked by Moderna chief's Covid warning

1 min read

Senior Investment and Markets Analyst at Hargreaves Lansdown, Susannah Streeter said: “Amid the pessimism about the effectiveness of vaccines, AstraZeneca is among the biggest fallers on the FTSE 100 so far.

“Its vaccine has been produced at cost and now investors are clearly wondering if they will ever see a profit from this part of the business.”

Pfizer and its partner BioNTech however have struck a more positive tone saying last week they could produce and ship an updated version of their vaccine within 100 days to tackle any immunity evasion from Omicron.

Pfizer saw a boost to its share price at the end of trading on Friday whilst BioNTech is currently up 4.17 percent.

Leave a Reply

Your email address will not be published.

Previous Story

Barely-driven 1987 Buick GNX muscle car sold for $236,000

Next Story

Liverpool boss Jurgen Klopp raises two issues with 'surprise' final Ballon d'Or standings

Latest from Blog

withemes on instagram